National Cancer Institute, Egypt
Clinical trials sponsored by National Cancer Institute, Egypt, explained in plain language.
-
Can extra chemo keep aggressive cancer at bay?
Disease control CompletedThis study tested whether continuing chemotherapy with the drug gemcitabine after initial treatment could help patients with advanced pleural mesothelioma keep their cancer from worsening longer. The trial involved 64 patients whose cancer had stabilized or responded to first-lin…
Phase: PHASE2 • Sponsor: National Cancer Institute, Egypt • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC
-
New nerve blocks battle Post-Surgery pain in cancer patients
Symptom relief CompletedThis study compared two different nerve-blocking techniques to manage pain after abdominal cancer surgery. Researchers tested which method provided better pain relief and reduced the need for strong painkillers like morphine. The trial involved 70 adults undergoing liver or kidne…
Phase: NA • Sponsor: National Cancer Institute, Egypt • Aim: Symptom relief
Last updated Apr 02, 2026 00:41 UTC
-
Simple vitamin tested to shield cancer patients from Chemo's painful side effect
Symptom relief CompletedThis study tested whether taking vitamin B daily could prevent or reduce painful nerve damage (peripheral neuropathy) caused by a common chemotherapy drug (paclitaxel) in women with ovarian cancer. Researchers compared 146 patients who took vitamin B preventively before starting …
Phase: NA • Sponsor: National Cancer Institute, Egypt • Aim: Symptom relief
Last updated Mar 23, 2026 15:17 UTC
-
New approach may reduce opioid need after breast surgery
Symptom relief CompletedThis study tested whether specific nerve blocks can better control pain after breast cancer surgery. Researchers enrolled 188 women to see if this technique delays the need for opioid painkillers after their operations. The goal was to find safer, more effective pain management o…
Phase: NA • Sponsor: National Cancer Institute, Egypt • Aim: Symptom relief
Last updated Mar 17, 2026 12:55 UTC